To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Global Electrophysiology Devices Market size was valued at USD 6.78 Billion in 2023 and is poised to grow from USD 7.54 Billion in 2024 to USD 15.81 billion by 2031, at a CAGR 11.16 % during the forecast period (2024-2031). 

The market is extremely competitive, with players pursuing new product development and large R&D investments as a long-term strategy. Companies around the world are pursuing an inorganic growth approach to expand product portfolios and gain a presence in the sector. For example, Boston Scientific Corp. finalized the acquisition of Baylis Medical firm Inc. in February 2022, a firm specializing in providing an advanced transseptal option for catheter-based treatments on the left side of the heart. 'Abbott Laboratories', 'Medtronic plc', 'Boston Scientific Corporation', 'Biosense Webster (a Johnson & Johnson company)', 'St. Jude Medical (part of Abbott Laboratories)', 'Siemens Healthineers', 'Koninklijke Philips N.V.', 'GE Healthcare', 'MicroPort Scientific Corporation', 'Biotronik SE & Co. KG', 'CardioFocus Inc.', 'LivaNova PLC', 'Penumbra, Inc.', 'Stereotaxis, Inc.', 'nContact, Inc. (part of AtriCure, Inc.)', 'Advanced Cardiac Therapeutics, Inc.', 'CathRx Ltd.', 'Osypka Medical GmbH', 'Auris Health, Inc. (part of Johnson & Johnson)', 'AngioDynamics, Inc.'

The growing prevalence of cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia, is a major driver of the electrophysiology devices market. These conditions require accurate diagnosis and treatment, which can be facilitated by electrophysiology devices.

Minimally invasive procedures: There is a growing trend towards minimally invasive procedures in the field of electrophysiology. Advances in technology and device design have enabled the development of catheter-based techniques that allow for precise diagnosis and treatment of cardiac arrhythmias with reduced patient discomfort, shorter recovery times, and lower risk of complications.

In 2023, the market for electrophysiology (EP) devices was dominated by North America, which had 48.3% of the global market share. The main factors driving this region's growth are the increased prevalence of cardiovascular disease, the sophisticated healthcare system, and the presence of important players. Furthermore, it is anticipated that the growing number of patients undergoing procedures and the increased public awareness of minimally invasive surgery will drive market expansion in North America. 

Feedback From Our Clients

Global Electrophysiology Devices Market

Product ID: SQMIG35A2420